Milestone Pharmaceuticals Inc. (MIST) Executive Compensation
Milestone Pharmaceuticals Inc. (MIST) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MIST
CIK: 1408443
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: A8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerGregory Tremellen
Audit LocationMontreal, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-03 | 2026-09-03 | FORM 8-K | 0001104659-26-105052 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | FORM 8-K | 0001104659-26-094466 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001104659-26-094435 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0002143027-26-000012 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-10 | FORM 8-K | 0001104659-26-074025 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001568850-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001573553-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001970274-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001634189-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001570392-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001616284-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001242215-26-000014 | View SEC Doc Filr Page |
| EFFECT | 2026-05-22 | — | EFFECT Filing | 9999999995-26-001747 | View SEC Doc Filr Page |
| CORRESP | 2026-05-20 | — | CORRESP Filing | 0001104659-26-064183 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-18 | — | UPLOAD Filing | 0000000000-26-005086 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001493215-26-000112 | View SEC Doc Filr Page |
| S-3 | 2026-05-13 | — | S-3 | 0001104659-26-060391 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0000919574-26-002920 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | FORM 8-K | 0001104659-26-059780 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001104659-26-059752 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001104659-26-052913 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001104659-26-052893 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-10 | FORM DEF 14A | 0001104659-26-052880 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 Filing | 0001437782-26-000010 | View SEC Doc Filr Page |
| 144 | 2026-04-16 | — | 144 Filing | 0001950047-26-003561 | View SEC Doc Filr Page |